PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...

Scientists have learned that prostate cancers can vary significantly among patients and that there are often differences within each patient's tumor. However, the study published Aug. 28 in Nature ...

Picking the right target and helping recruit a wider range of anti-tumor immune cells can help improve CAR-T cell therapy against advanced prostate cancer, according to new preclinical work from Fred ...

Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful chemotherapy medications — cisplatin. Now, researchers reporting in ACS Central Science ...

In a recent study published in the journal eBioMedicine, researchers attempted to identify, characterize, and quantify microplastics (including their abundances and types) found in human prostate ...

Prostate cancer is the leading cause of cancer and the second leading cause of cancer deaths in American men. Tumors often grow slowly and develop in individuals older than 65. But certain inherited ...

Scientists have learned that prostate cancers can vary significantly among patients and that there are often differences within each patient's tumor. However, the study published Aug. 28 in Nature ...

Please provide your email address to receive an email when new articles are posted on . A diet with reduced omega-6 and increased omega-3 fatty acids could slow progression of prostate cancer. The ...